Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Cervical Cancer

Free Subscription 19.01.2026 1 Adv Radiat Oncol 1 Am J Med 1 Ann Ital Chir 1 Apoptosis 1 Aten Primaria 1 Biomed Pharmacother 1 BMC Cancer 1 BMC Mol Cell Biol 1 BMJ Glob Health 1 BMJ Open 1 Cancer Gene Ther 1 Cancer Med 1 Cancer Nanotechnol 2 Clin Transl Radiat Oncol 2 Discov Oncol 3 Eur J Med Res 2 Eur J Obstet Gynecol Reprod Biol 1 FASEB J 1 Gan To Kagaku Ryoho 3 Gynecol Oncol 1 Hum Vaccin Immunother 1 Infect Med (Beijing) 1 Int J Biochem Cell Biol 1 Int J Cancer 2 Int J Gynaecol Obstet 2 Int J Gynecol Cancer 1 JCO Glob Oncol 1 Mol Biol Rep 1 Mol Oncol 1 Nature 1 PeerJ 1 Photochem Photobiol 1 PLoS One 1 Prev Med 1 Quant Imaging Med Surg 1 Res Sq 1 Sci Rep 1 Sichuan Da Xue Xue Bao Yi Xue Ban 1 Singapore Med J 1 Syst Rev 1 Transl Oncol 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Radiat Oncol

1. ZHENG Z, Sun S, Zhu J, Jiang Q, et al
   Relationship Between Intestinal Flora and Acute Radiation Enteritis in Patients With Advanced Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
   Adv Radiat Oncol. 2025;11:101968.
   PubMed         Abstract available
   
   

   
   Am J Med

2. BECK JB, Morenz AM
   Updates in Cervical Cancer Screening: A Practical Guide for the Internist.
   Am J Med. 2026 Jan 9:S0002-9343(26)00014-8. doi: 10.1016/j.amjmed.2025.
   PubMed         Abstract available
   
   

   
   Ann Ital Chir

3. ZHANG J, Feng J, Yin C, Dong Z, et al
   The Impact of Anesthesia and Surgical Intervention on Liver and Kidney Function in Patients With Gynecological Malignancies.
   Ann Ital Chir. 2026;97:175-184.
   PubMed         Abstract available
   
   

   
   Apoptosis

4. CAO Z, Yang S, Zou J, Jin Y, et al
   CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis.
   Apoptosis. 2026;31:41.
   PubMed         Abstract available
   
   

   
   Aten Primaria

5. ESTUPINAN RUIZ CA, Morales Doncel RD, Hincapie-Carvajal JA
   [Public health and cervical cancer in Latin America: the impact of health spending and legislation on prevention in three countries].
   Aten Primaria. 2026;58:103427.
   PubMed         Abstract available
   
   

   
   Biomed Pharmacother

6. BLAZEJCZYK I, Daniluk T, Toczylowski K, Gorbacz-Kononczuk J, et al
   Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.
   Biomed Pharmacother. 2026;194:118928.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. WANG Y, Deng Y, Wei Y, Wang C, et al
   Association of SMAD4 gene polymorphisms with human papillomavirus infection and risk of cervical cancer: a case-control study.
   BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15552.
   PubMed        
   
   

   
   BMC Mol Cell Biol

8. YANG W, Liu S, Shang D, Liu P, et al
   Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription.
   BMC Mol Cell Biol. 2026 Jan 16. doi: 10.1186/s12860-026-00566.
   PubMed        
   
   

   
   BMJ Glob Health

9. BOSE S, Mandal R, Sengupta S, Dutta S, et al
   Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting.
   BMJ Glob Health. 2026;11:e021707.
   PubMed         Abstract available
   
   

   
   BMJ Open

10. AMANKWAH I, Gone M, Jaliu A, Morand M, et al
    Breast and cervical cancer care in Ghana: a qualitative exploratory study of stakeholder perspectives on National Health Insurance Scheme coverage.
    BMJ Open. 2026;16:e098784.
    PubMed         Abstract available
    
    

    
    Cancer Gene Ther

11. ZHANG Y, Yan L, An N, Geng J, et al
    TFF3 sensitizes cervical carcinoma cells to cisplatin toxicity by binding to IGF2R.
    Cancer Gene Ther. 2026;33:155-168.
    PubMed         Abstract available
    
    

    
    Cancer Med

12. RAMOS-PIBERNUS A, Bermonti-Perez M, Mejias-Serrano D, Moreta-Avila F, et al
    Development of a Culturally Sensitive Intervention for Cervical Cancer Screening Promotion for Latinx Transgender Individuals.
    Cancer Med. 2026;15:e71494.
    PubMed         Abstract available
    
    

    
    Cancer Nanotechnol

13. ZHOU Y, Cheng S, Shu L, He W, et al
    Quercetin-Fe nanodots inhibit cervical cancer cell proliferation by targeting PCNA.
    Cancer Nanotechnol. 2026;17:2.
    PubMed         Abstract available
    
    

    
    Clin Transl Radiat Oncol

14. VAN NOORTWIJK R, Kroon PS, van Vliet-van den Ende KM, Brondijk EH, et al
    Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer.
    Clin Transl Radiat Oncol. 2025;57:101098.
    PubMed         Abstract available
    
    
15. MISZCZYK M, Wu T, Kuna K, Stankiewicz M, et al
    Corrigendum to "Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials". [Clin. Translat. Radiat. Oncol. 47 (2024) 100801].
    Clin Transl Radiat Oncol. 2025;56:101057.
    PubMed         Abstract available
    
    

    
    Discov Oncol

16. LI C, Lin H, Zhang H
    Transcriptomic profiling of T cell exhaustion mechanisms in cervical cancer pathogenesis.
    Discov Oncol. 2026 Jan 16. doi: 10.1007/s12672-026-04423.
    PubMed        
    
    
17. SU X, Wu H, Chen X, Ouyang Y, et al
    Comparison of efficacy and safety of definitive chemoradiotherapy for cervical cancer patients of different age groups using propensity score matching.
    Discov Oncol. 2026 Jan 13. doi: 10.1007/s12672-026-04392.
    PubMed         Abstract available
    
    

    
    Eur J Med Res

18. GUO S, Lin H, Chen Y, Hu Q, et al
    A study on strategies to optimize bladder volume consistency in radiotherapy patients.
    Eur J Med Res. 2025;31:81.
    PubMed         Abstract available
    
    
19. YING Z, Shi M, Gong W, Chen Y, et al
    g(E)-pHLIP promote virus immunity to destroy cervical cancer cell.
    Eur J Med Res. 2026 Jan 14. doi: 10.1186/s40001-025-03787.
    PubMed         Abstract available
    
    
20. CHENG L, Guo C, Yang Y
    Correlation and combined predictive value analysis of serum IL-6 and IL-10 levels with tumor progression in patients with cervical cancer.
    Eur J Med Res. 2026 Jan 12. doi: 10.1186/s40001-025-03791.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

21. LUO MY, Williams CYK
    Application and validation of AI-driven methods to explore patient experiences of pre-cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114953.
    PubMed         Abstract available
    
    
22. CHATTERJEE R, Nobbenhuis M, Kasius J, Kaur M, et al
    Robotic indocyanine green-guided sentinel lymph node mapping in early-stage cervical cancer: The fluorescent robotic indocyanine endoscopic node detection series (FRIENDS).
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114927.
    PubMed         Abstract available
    
    

    
    FASEB J

23. XUE L, Zhou S, Tang L, Li G, et al
    EM2, a Novel Elephantopus mollis H.B.K. Monomer, Enhances Radiosensitivity in Cervical Cancer Through Dual Inhibition of AKT and Autophagy.
    FASEB J. 2026;40:e71454.
    PubMed         Abstract available
    
    

    
    Gan To Kagaku Ryoho

24. ICHINOHE D, Umehara Y, Fujita H, Yamauchi Y, et al
    [A Case of Laparoscopic Lateral Segmentectomy for Metachronous Liver Metastasis from Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:1053-1054.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

25. KIM SI, Kim JW, Kwon JS, Ferguson SE, et al
    Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
    Gynecol Oncol. 2026;205:37-45.
    PubMed         Abstract available
    
    
26. NISHA M, Liang YL, Bateson D, Saville M, et al
    Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program.
    Gynecol Oncol. 2025;204:133-142.
    PubMed         Abstract available
    
    
27. FAN KY, Chehade R, Wang AY, Sachdeva A, et al
    Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis.
    Gynecol Oncol. 2026;204:118-123.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

28. BHENGU P, Wiysonge CS, Magasana V, Cooper S, et al
    Healthcare workers' and caregivers' knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu-Natal Province, South Africa.
    Hum Vaccin Immunother. 2026;22:2613571.
    PubMed         Abstract available
    
    

    
    Infect Med (Beijing)

29. PAKDEL T, Kargar M, Farhadi A, Aghdaei MH, et al
    MCPyV small T antigen enhances HPV16 oncogene expression, promotes Ca Ski cell proliferation, and reduces 5-fluorouracil-induced apoptosis in cervical cancer cells.
    Infect Med (Beijing). 2025;4:100222.
    PubMed         Abstract available
    
    

    
    Int J Biochem Cell Biol

30. LI Y, Zhao J, Li M, Cheng Y, et al
    Xiaoyou decoction suppresses cervical precancerous lesions through the activation of cellular autophagy and the upregulation of p53 expression.
    Int J Biochem Cell Biol. 2026;191:106894.
    PubMed         Abstract available
    
    

    
    Int J Cancer

31. CUI J, Mukherjee A, Patel PG, Junkins A, et al
    Sex and organ-specific risk and temporal trends of human papillomavirus-associated anogenital cancer among solid organ transplant recipients in the United States.
    Int J Cancer. 2026;158:1507-1516.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

32. ZHANG H, Dai Y, Zhou H, Yang Y, et al
    Application of P16/Ki-67 dual-staining for the detection of high-grade cervical lesions in the triage of patients with minor abnormal cytology: A meta-analysis.
    Int J Gynaecol Obstet. 2026;172:815-827.
    PubMed         Abstract available
    
    
33. DUQUE CAB, Bach RB, Fleider L, Sanchez-Diaz E, et al
    Colposcopists' practice patterns in Latin America: An international cross-sectional survey.
    Int J Gynaecol Obstet. 2026;172:808-814.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

34. LEVIN G, Leung SOA
    Correspondence on "Multicenter validated machine learning model for cervical cancer based on HPV genotyping results" by Ziren Chen et al.
    Int J Gynecol Cancer. 2025 Dec 23:104447. doi: 10.1016/j.ijgc.2025.104447.
    PubMed        
    
    
35. CASARIN J, Meschini T, Schivardi G, Giudici A, et al
    Determinants of adjuvant radiotherapy in early-stage cervical cancer: a retrospective analysis of the SUCCOR cohort.
    Int J Gynecol Cancer. 2025;36:104448.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

36. ZAHIROVA N, Tillyashaykhov M, Egamberdiev D, Lucas E, et al
    Lessons Learned From Evaluation of a Human Papillomavirus Screening Pilot in Uzbekistan.
    JCO Glob Oncol. 2026;12:e2500250.
    PubMed         Abstract available
    
    

    
    Mol Biol Rep

37. RAECK J, da Silva JB, Carvalho L, Salgado L, et al
    Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.
    Mol Biol Rep. 2026;53:283.
    PubMed         Abstract available
    
    

    
    Mol Oncol

38. TOES-ZOUTENDIJK E, Arbyn M, Auvinen A, Baldwin D, et al
    European Code Against Cancer, 5th edition - organised cancer screening programmes.
    Mol Oncol. 2026;20:134-153.
    PubMed         Abstract available
    
    

    
    Nature

39. 
    HPV vaccine could help to protect the unvaccinated against cervical cancer.
    Nature. 2026 Jan 16. doi: 10.1038/d41586-026-00128.
    PubMed        
    
    

    
    PeerJ

40. YUAN L, Wen B, Li X, Liu F, et al
    Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China.
    PeerJ. 2026;14:e20509.
    PubMed         Abstract available
    
    

    
    Photochem Photobiol

41. DUSHKIN A, Maxim A, Oxana S, Stanislav A, et al
    Effect of photodynamic therapy on the expression of toll-like receptor 2, -3, -4, and -8 in the cervical lesions.
    Photochem Photobiol. 2026;102:141-153.
    PubMed         Abstract available
    
    

    
    PLoS One

42. TANIOKA M, Nagao S, Ida N, Tanaka Y, et al
    Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol.
    PLoS One. 2026;21:e0340963.
    PubMed         Abstract available
    
    

    
    Prev Med

43. ULMER KK, Soltani LF, Addis I, Young AP, et al
    Major changes in cervical cancer screening in the US.
    Prev Med. 2026 Jan 14:108512. doi: 10.1016/j.ypmed.2026.108512.
    PubMed        
    
    

    
    Quant Imaging Med Surg

44. FENG H, Yoshida E, Sheng K
    Multimodality and temporal analysis of cervical cancer treatment response.
    Quant Imaging Med Surg. 2026;16:78.
    PubMed         Abstract available
    
    

    
    Res Sq

45. OKUNADE KS, Soibi-Harry A, Fayinto AI, Adelabu H, et al
    Effect of Socioeconomic Status on Cervical Cancer Screening Behaviour Among Mothers of Adolescent Girls in Lagos, Nigeria: A Secondary Analysis of the mHealth-HPVac Study.
    Res Sq [Preprint]. 2026 Jan 9:rs.3.rs-8126074. doi: 10.21203/rs.3.rs-8126074.
    PubMed         Abstract available
    
    

    
    Sci Rep

46. WUBINEH BZ, Rusiecki A, Halawa K
    Deep learning-based automatic segmentation and classification for cervical cancer detection using an improved U-Net and ensemble methods.
    Sci Rep. 2026 Jan 13. doi: 10.1038/s41598-026-35299.
    PubMed        
    
    

    
    Sichuan Da Xue Xue Bao Yi Xue Ban

47. LAN T, Yao X, Zhou X, Shi L, et al
    [Clinicopathological Characteristics of Cervical Neuroendocrine Carcinoma and Their Relationship With Prognosis].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:1633-1640.
    PubMed         Abstract available
    
    

    
    Singapore Med J

48. KWEK ME, Ang JX, Mathur M, Kho LCL, et al
    Comparison of awareness, attitudes and knowledge on human papilloma virus vaccination in Singapore: 2019 versus 2013.
    Singapore Med J. 2025;66:596-600.
    PubMed         Abstract available
    
    

    
    Syst Rev

49. PILLAY J, Gates A, Guitard S, Zakher B, et al
    Correction: Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care.
    Syst Rev. 2026;15:9.
    PubMed        
    
    

    
    Transl Oncol

50. JIA Y, Zhang F, Zou K, Zou L, et al
    Corrigendum to "A Clinical Study on the Efficacy of Concurrent Chemoradiotherapy Combined with Targeted Therapy and Hyperthermia in Patients with Locally Advanced Cervical Cancer" [Translational Oncology,Volume61, November 2025, 102516].
    Transl Oncol. 2026;64:102656.
    PubMed        
    
    

    
    Vaccine

51. NONBOE MH, Napolitano G, Schroll JB, Andersen B, et al
    Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study.
    Vaccine. 2025;73:128142.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum